-
TJX Group President Kenneth Canestrari to retire April 30, 2027; steps down as executive officer Jan 31, 2027
TJX entered a letter agreement with Kenneth Canestrari, Senior EVP, Group President, on October 15, 2026, amending his employment agreement dated February 2, 2018 (last amended February 2, 2024).
-
TJX elects Craig A. Pintoff, United Rentals EVP, to board and audit committee
Craig A. Pintoff, 56, EVP & Chief Administrative Officer of United Rentals (NYSE: URI), elected to TJX board effective Sept 16, 2026.
-
TJX Q2 FY27 EPS $1.36 beats, comps +4%; raises FY27 EPS and margin guidance
Q2 net sales $15.2B (+5% YoY); comp sales +4% above plan; diluted EPS $1.36 (+24%), adjusted $1.22 (+11%).
-
TJX shareholders elect all 10 director nominees, ratify auditor, approve say-on-pay
All 10 director nominees elected with majority support; no nominee received less than 85% of votes cast.
-
TJX Q1 FY27 EPS $1.19 beats plan, comp sales +6%; raises full-year guidance
Q1 diluted EPS $1.19 (+29% YoY) on net sales $14.3B (+9%), pretax margin 12.0% (+1.7 ppts), all well above plan.
-
TJX Q4 adj. EPS $1.43, comp +5% beat plan; dividend up 13%; FY27 buyback $2.5-$2.75B
Q4 comp sales +5% well above plan; adj. EPS $1.43 (+16% YoY); net sales $17.7B (+9%).
-
TJX Q3 FY26 beats: comp +5%, EPS $1.28 (+12%); raises full-year guidance
Q3 consolidated comp sales +5%, net sales $15.1B (+7% YoY); diluted EPS $1.28 vs $1.14 (+12%).
-
TJX Q2 EPS $1.10 beats plan, comp sales +4%, raises FY26 EPS guidance to $4.52-$4.57
Q2 net sales $14.4B (+7% YoY); consolidated comp sales +4%, above plan; diluted EPS $1.10 (+15% vs $0.96).
-
TJX annual meeting: All director nominees elected, auditor ratified, say-on-pay approved
All 10 director nominees elected with large majorities (lowest 863M for, 80M against for Amy B. Lane).
-
TJX Q1 EPS $0.92 beats plan; comps +3%; maintains FY26 guidance
Q1 net sales $13.1B (+5% YoY); consolidated comp sales +3% at high end of plan.
-
TJX amends revolving credit facilities; extends maturities to 2029/2030, maintains $1.5B capacity
Amended $500M facility to $750M with maturity extended to May 9, 2029.
-
TJX Q4 comps +5%, EPS $1.23 beat; guides FY26 EPS $4.34-$4.43, raises dividend 13%
Q4 diluted EPS $1.23, up 10% vs. prior-year adjusted $1.12; FY25 EPS $4.26, up 13% vs. adjusted $3.76.
-
TJX extends CEO Herrman, Exec Chairman Meyrowitz employment to Jan 2028, sets Meyrowitz salary at $1.1M
CEO and President Ernie Herrman and Executive Chairman Carol Meyrowitz employment extended to January 29, 2028.
-
TJX Q3 FY25 EPS $1.14 beats plan; comps +3% at high-end; raises full-year guidance
Net sales $14.1B (+6% YoY); consolidated comp store sales +3% driven entirely by customer transactions.
-
TJX amends bylaws to add universal proxy rules and procedural updates for director nominations
Bylaws amended effective Sept 18, 2024 to address universal proxy rules per Rule 14a-19.
-
TJX Q2 EPS $0.96 beats plan; comps +4%; raises full-year outlook; invests $360M in Brands For Less
Q2 diluted EPS $0.96 (vs $0.85 last year, +13%), pretax profit margin 10.9% (+0.5pp), comp store sales +4%.
-
TJX shareholders re-elect all director nominees, approve say-on-pay, reject social compliance proposal
All 10 director nominees elected with strong support; lowest vote share was 88% for Amy B. Lane.
-
TJX Q1 comps +3%, EPS $0.93 (+22%), raises FY25 profit margin and EPS guidance
Q1 net sales $12.5B (+6% YoY); comp store sales +3% driven entirely by increased customer transactions.
-
TJX Q4 EPS $1.22 beats plans; comps +5%; guides FY25 EPS $3.94-$4.02
Q4 diluted EPS $1.22 (+37% YoY); adjusted EPS $1.12 (+26% YoY) on $16.4B revenue (+13%).
-
TJX promotes John Klinger to Sr. EVP/CFO; Scott Goldenberg moves to advisory role, no longer exec officer
John Klinger promoted to Senior EVP, CFO effective Feb 4, 2024; base salary $825,000, MIP target 85%, LRPIP $450k, SIP target $2.9M.
-
TJX Q3 beats: comp sales +6%, EPS $1.03; raises FY24 comp and EPS guidance
Net sales $13.3B (+9% YoY), comp store sales +6% driven entirely by customer traffic; Marmaxx +7%, HomeGoods +9%.
-
TJX elects Vertex CFO Charles F. Wagner Jr. to its Board of Directors
Charles F. Wagner, Jr., EVP and CFO of Vertex Pharmaceuticals, elected to TJX Board and Audit & Finance Committee effective Sept 20, 2023.
-
TJX Q2 FY24 EPS $0.85 (+23%) beats plan; raises full-year guidance
Q2 net sales $12.8B (+8% YoY); overall comp store sales +6%, entirely traffic-driven.
-
Senior EVP Richard Sherr to retire July 14; enters consulting agreement through April 2024
Richard Sherr, Senior EVP, retiring July 14, 2023; will consult from Aug 1, 2023 to Apr 30, 2024.
-
TJX Q1 pretax margin 10.3% beats plan; EPS $.76; raises FY24 guidance
Net income $891M, diluted EPS $.76, up 55% YoY; adjusted EPS up 12% vs prior year adj. EPS of $.68.
-
TJX amends $500M and $1B credit facilities; extends $500M facility maturity to 2028
$500M revolving credit facility maturity extended from May 2024 to May 8, 2028.
-
TJX Q4 EPS $0.89 (+14% YoY), revenue $14.5B (+5%); plans 13% dividend increase, $2-2.5B buyback in FY24
Q4 diluted EPS $0.89, up 14% YoY; revenue $14.5B, up 5% YoY; U.S. comp sales +4% (above plan).
-
TJX Q3 EPS $0.91 beats; raises Q4 comp guidance; Marmaxx +3%
Net sales $12.2B (-3%); diluted EPS $0.91, adjusted $0.86; pretax margin 11.2%; all above plan.
-
TJX promotes John Klinger to CFO effective Jan 29, 2023; current CFO Goldenberg to Senior EVP, Finance.
John Klinger promoted to EVP, CFO effective Jan 29, 2023; will serve as principal financial and accounting officer.
-
Director John F. O'Brien resigns from TJX Board due to illness
John F. O'Brien resigned from the Board on November 9, 2022, effective immediately.
-
TJX Q2 EPS $0.69 meets high end; guides FY23 EPS down to $2.87-$2.95
Q2 net sales $11.8B (-2% YoY); U.S. comp store sales -5% vs +21% open-only comp last year.
-
TJX shareholders reject say-on-pay; approve stock plan with 27M new shares
Advisory say-on-pay vote failed: 48.7% for vs 49.4% against (excluding broker non-votes).
-
TJX Q1 adjusted EPS $0.68 beats plans; raises FY23 adjusted pretax margin outlook to 9.6%-9.8%
Q1 net sales $11.4B +13% YoY; U.S. comp flat, Marmaxx comp +3% driven by traffic.
-
TJX plans phased retirement of Senior EVP Richard Sherr through July 2023; transition to Mizzi
Sherr reduces to 80% schedule July 11, 2022; ceases as executive officer Jan 29, 2023; retires July 14, 2023.
-
TJX to divest 25% Familia stake after Russia invasion; potential $186M impairment
Commits to sell equity in Familia, a Russian off-price retailer with 400+ stores, due to Ukraine invasion.
-
TJX reports Q4 FY22 net sales $13.9B, EPS $0.78; raises dividend 13%, plans $2.25-$2.5B buyback
Q4 FY22 net sales $13.9B (+14% vs Q4 FY20); diluted EPS $0.78 vs $0.81 in Q4 FY20.
-
TJX extends CEO Herrman and Exec Chair Meyrowitz employment to Feb 1, 2025; Herrman gets $1.7M base, 200% bonus target
Ernie Herrman and Carol Meyrowitz entered into letter agreements extending their employment terms to February 1, 2025.
-
TJX Senior EVP Richard Sherr adopts Rule 10b5-1 trading plan
Plan allows exercise of options and/or sale of shares on open market starting at least 30 days after Nov 18, 2021.
-
TJX Q3 FY22 EPS $0.84 (+24% vs FY20); raises FY22 buyback to $1.75-2.0B
Net sales of $12.5B, +20% vs Q3 FY20; overall open-only comp store sales +14% vs Q3 FY20.
-
TJX Q2 FY22 beats plan: net sales $12.1B, open-only comp +20% vs FY20, EPS $0.64
Q2 FY22 net sales $12.1B (+23% vs Q2 FY20); diluted EPS $0.64 (includes $0.15 debt charge) vs $0.62 in Q2 FY20.